ESMO 2025: Data, decisions, and the future of oncology
This year’s congress showcased remarkable progress across multiple fronts, from next-generation immunotherapies and antibody-drug conjugates (ADCs) to the accelerating role of AI-driven…
This year’s congress showcased remarkable progress across multiple fronts, from next-generation immunotherapies and antibody-drug conjugates (ADCs) to the accelerating role of AI-driven…
In the fast-paced environment of pharmaceutical innovation, bioconjugation has proved to be a cornerstone technology. By enabling the precise modification…
AI is revolutionizing drug discovery with its ability to analyze vast datasets. Particularly beneficial in the early drug discovery phase,…
In the US alone, over 7,000 different rare diseases affect more than 30 million people[i]. Many of these conditions are…
What are Alum Products, and why are they challenging to fill? Alum products, commonly referring to aluminum-based adjuvants, play a…
The biotech industry is experiencing an unprecedented transformation, marked by complex market dynamics, shifting global innovation patterns and evolving investment…
In a recent webinar, Marc McArdle, CLA Customer Success Manager, was joined by Jackie Marchington, Head of Compliance and Ethics…
Container Closure Integrity Testing (CCIT) is an assay that evaluates a container closure system and its ability to maintain a…
Li predicts that symbiosis between 5G-A and AI technologies will stimulate double-digit growth in both DOU (data of usage) and…
The pharmaceutical industry is facing growing complexity in clinical trials, contributing to longer timelines and ultimately higher costs. These complexities…